Header cover image
  • Investing Ideas
  • /
  • Egyptian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

Egyptian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

Results

1

0 new

A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.

1 companies

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)

Market Cap: ج.م6.2b

Produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt.

RMDA

ج.م4.13

7D

-1.4%

1Y

25.2%